GILD vs. MDA.TO
GILD (Gilead Sciences, Inc.) and MDA.TO (MDA Space Ltd.) are both stocks. GILD operates in Drug Manufacturers - General (Healthcare), while MDA.TO operates in Aerospace & Defense (Industrials). Over the past 5 years, GILD returned 17.59%/yr vs 25.95%/yr for MDA.TO. At a 0.05 correlation, their price movements are largely independent.
Performance
GILD vs. MDA.TO - Performance Comparison
Loading charts...
Different Trading Currencies
GILD is traded in USD, while MDA.TO is traded in CAD. To make them comparable, the MDA.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GILD achieves a 4.96% return, which is significantly lower than MDA.TO's 99.11% return.
GILD
- 1D
- -0.82%
- 1M
- -2.46%
- YTD
- 4.96%
- 6M
- 7.00%
- 1Y
- 16.94%
- 3Y*
- 21.99%
- 5Y*
- 17.59%
- 10Y*
- 8.00%
MDA.TO
- 1D
- 0.66%
- 1M
- 11.96%
- YTD
- 99.11%
- 6M
- 119.52%
- 1Y
- 78.83%
- 3Y*
- 84.50%
- 5Y*
- 25.95%
- 10Y*
- —
GILD vs. MDA.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 4.96% | 36.59% | 18.68% | -1.99% | 23.63% | 13.03% |
MDA.TO MDA Space Ltd. | 99.11% | -5.47% | 136.33% | 84.39% | -36.65% | -33.73% |
Correlation
The correlation between GILD and MDA.TO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Apr 7, 2021 | 0.05 |
Fundamentals
GILD:
$160.64B
MDA.TO:
CA$7.17B
GILD:
$7.35
MDA.TO:
CA$0.81
GILD:
17.43
MDA.TO:
66.38
GILD:
0.04
MDA.TO:
0.27
GILD:
5.40
MDA.TO:
4.00
GILD:
6.83
MDA.TO:
3.88
GILD:
$29.74B
MDA.TO:
CA$1.75B
GILD:
$18.74B
MDA.TO:
CA$366.40M
GILD:
$12.88B
MDA.TO:
CA$291.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GILD vs. MDA.TO — Risk / Return Rank
GILD
MDA.TO
GILD vs. MDA.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and MDA Space Ltd. (MDA.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GILD | MDA.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.59 | ||
| Sortino ratioReturn per unit of downside risk | -0.62 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.25 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | 1.46 | -0.49 |
| Martin ratioReturn relative to average drawdown | 2.35 | 3.15 | -0.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GILD | MDA.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.65 | 1.24 | -0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.74 | 0.53 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.53 | -0.15 |
Drawdowns
GILD vs. MDA.TO - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.83%, roughly equal to the maximum MDA.TO drawdown of -70.91%. Use the drawdown chart below to compare losses from any high point for GILD and MDA.TO.
Loading charts...
Drawdown Indicators
| GILD | MDA.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.83% | -70.91% | +0.08% |
Max Drawdown (1Y)Largest decline over 1 year | -17.65% | -54.42% | +36.77% |
Max Drawdown (3Y)Largest decline over 3 years | -26.59% | -54.42% | +27.83% |
Max Drawdown (5Y)Largest decline over 5 years | -26.59% | -68.48% | +41.89% |
Max Drawdown (10Y)Largest decline over 10 years | -30.47% | — | — |
Current DrawdownCurrent decline from peak | -17.31% | -20.13% | +2.82% |
Average DrawdownAverage peak-to-trough decline | -22.16% | -32.46% | +10.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.22% | 25.11% | -17.89% |
Volatility
GILD vs. MDA.TO - Volatility Comparison
The current volatility for Gilead Sciences, Inc. (GILD) is 6.75%, while MDA Space Ltd. (MDA.TO) has a volatility of 19.31%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than MDA.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GILD | MDA.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.75% | 19.31% | -12.56% |
Volatility (6M)Calculated over the trailing 6-month period | 18.45% | 44.24% | -25.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.29% | 64.17% | -37.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.03% | 49.48% | -25.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.49% | 49.58% | -24.09% |
Dividends
GILD vs. MDA.TO - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 2.49%, while MDA.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.49% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
MDA.TO MDA Space Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
GILD vs. MDA.TO - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and MDA Space Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GILD vs. MDA.TO - Profitability Comparison
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
MDA.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MDA Space Ltd. reported a gross profit of 84.00M and revenue of 464.10M. Therefore, the gross margin over that period was 18.1%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
MDA.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MDA Space Ltd. reported an operating income of 32.30M and revenue of 464.10M, resulting in an operating margin of 7.0%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
MDA.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MDA Space Ltd. reported a net income of 29.60M and revenue of 464.10M, resulting in a net margin of 6.4%.
Frequently Asked Questions
GILD and MDA.TO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GILD and MDA.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer